BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$665M |
| 2 |
Apple
AAPL
|
+$408M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$402M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$223M |
| 5 |
NVIDIA
NVDA
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.87B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$970M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$389M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$350M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.77% |
| 2 | Consumer Discretionary | 6.67% |
| 3 | Healthcare | 6.55% |
| 4 | Financials | 6.32% |
| 5 | Communication Services | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Biglari Holdings Class B
BH
$1.23B
| $23.2K | ﹤0.01% |
189
-780
| -80% | -$105K |
|
3502
Carlyle Secured Lending
CGBD
$764M
| $22.8K | ﹤0.01% |
1,799
-1,954
| -52% | -$27.4K |
|
3503
KALA BIO
KALA
$17.1M
| $22.6K | ﹤0.01% |
30
+28
| +1,400% | +$43.9K |
|
3504
First Northwest Bancorp
FNWB
$107M
| $22.2K | ﹤0.01% |
+1,421
| New | +$26.4K |
|
3505
NLI Holdings
NL
$329M
| $22.1K | ﹤0.01% |
2,236
+757
| +51% | +$6.08K |
|
|
APLT
3506
DELISTED
Applied Therapeutics
APLT
| $21.8K | ﹤0.01% |
22,954
+21,415
| +1,391% | +$35.1K |
|
3507
Global X US Infrastructure Development ETF
PAVE
$14.3B
| $21.4K | ﹤0.01% |
941
+606
| +181% | +$15.5K |
|
|
DRRX
3508
DELISTED
DURECT Corp
DRRX
| $20.9K | ﹤0.01% |
4,378
+2,119
| +94% | +$10.1K |
|
3509
Citius Pharmaceuticals
CTXR
$21M
| $20.4K | ﹤0.01% |
885
+331
| +60% | +$9.07K |
|
|
CEQP
3510
DELISTED
Crestwood Equity Partners LP
CEQP
| $20.2K | ﹤0.01% |
838
-210,433
| -100% | -$6.05M |
|
|
CLSD
3511
DELISTED
Clearside Biomedical
CLSD
| $20.2K | ﹤0.01% |
914
-61
| -6% | -$1.48K |
|
3512
Spero Therapeutics
SPRO
$68.9M
| $20.1K | ﹤0.01% |
27,176
+24,668
| +984% | +$71.7K |
|
3513
Northrim BanCorp
NRIM
$599M
| $20.1K | ﹤0.01% |
2,000
-4,064
| -67% | -$41.7K |
|
3514
Atossa Therapeutics
ATOS
$23.5M
| $19.9K | ﹤0.01% |
1,215
-989
| -45% | -$15.6K |
|
3515
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $19.8K | ﹤0.01% |
507
-704
| -58% | -$29.8K |
|
|
CLPR
3516
Clipper Realty
CLPR
$50.9M
| $19.6K | ﹤0.01% |
2,533
-2,451
| -49% | -$21K |
|
3517
FS Bancorp
FSBW
$325M
| $19.5K | ﹤0.01% |
678
-1,329
| -66% | -$39.4K |
|
3518
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $19.3K | ﹤0.01% |
587
-19,740
| -97% | -$668K |
|
3519
Petrobras Class A
PBR.A
$103B
| $19.3K | ﹤0.01% |
1,814
-1,966
| -52% | -$24.8K |
|
|
TRHC
3520
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $18.7K | ﹤0.01% |
7,282
-30,410
| -81% | -$114K |
|
3521
Verastem
VSTM
$629M
| $18.3K | ﹤0.01% |
1,314
+130
| +11% | +$2.07K |
|
3522
HSBC
HSBC
$358B
| $17K | ﹤0.01% |
521
+361
| +226% | +$11.7K |
|
|
CAMP
3523
DELISTED
CalAmp Corp.
CAMP
| $16.5K | ﹤0.01% |
172
-212
| -55% | -$29.5K |
|
3524
Barnes & Noble Education
BNED
$417M
| $16.2K | ﹤0.01% |
55
-171
| -76% | -$49.6K |
|
3525
InfuSystem Holdings
INFU
$244M
| $16K | ﹤0.01% |
1,666
-81
| -5% | -$709 |
|
Similar funds
BNP Paribas Financial Markets's Q2 2022 Portfolio in Review
As of Q2 2022, BNP Paribas Financial Markets held 4,360 positions worth $64.1B, down 14% from $74.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets's Q2 2022 filing shows 217 new, 1,899 increased, 1,581 reduced and 272 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M. The largest sale was Invesco QQQ Trust, an estimated $1.87B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2022 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 500,000 shares worth $31.5M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2022, an estimated $665M increase.
- BNP Paribas Financial Markets's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.87B.
- BNP Paribas Financial Markets fully exited Warner Bros in Q2 2022, selling an estimated $27.5M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $64.1B portfolio in Q2 2022.
- BNP Paribas Financial Markets opened 217 new positions and closed 272 in Q2 2022.
- BNP Paribas Financial Markets's portfolio value fell 14% quarter-over-quarter to $64.1B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.